Remove tag new-technologies
article thumbnail

3 Things Generative AI Can Do for Commercial Pharma Right Now

PM360

Will this next-generation technology usher in a bold creative revolution that upends much of how we go about our business every day? And there is every reason to believe that, if managed adeptly, this technology will be transformative. Auto-tagging, a laborious task, is another area where generative AI/LLMs can assist.

Pharma 97
article thumbnail

BD partners with Biocorp on connected self-injection devices

pharmaphorum

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What Tech Trends Do Life Sciences Marketers Need to Know About?

PM360

To discover how technology is affecting the jobs of life sciences marketers we turned straight to the source—our readers. What technology will have the biggest impact on the industry within the next three years? Another capability made possible by fine-tuning is the enhancement of content tagging.

article thumbnail

EVERSANA and Amazon Web Services Introduce Transformative Medical & Regulatory Review AI Solution

PM360

The new offering from EVERSANA automates the content fact-checking and approval portion of the process leveraging generative AI and Natural Language Processing (NLP) services from AWS. The new offering is the first of several new EVERSANA solutions in development leveraging AWS.

Medical 52
article thumbnail

Medicare savings won’t make a dent in healthcare costs

World of DTC Marketing

If pharma is a business, they will find a way to develop, buy, or acquire new drugs. New technologies are being developed that allow for virtual clinical trials and other cost-lowering development costs. But even though the government may be saving money, ordinary taxpayers probably won’t see any discounts.

article thumbnail

Oligonucleotide synthesis market to reach $16.7 billion by 2027

European Pharmaceutical Review

According to a new market report by ResearchAndMarkets, the global oligonucleotide synthesis market is projected to reach $16.7 Agilent Technologies, Inc. (US). Tag Copenhagen A/S (Denmark). The research projected a compound annual growth rate (CAGR) of 16.8 percent from $7.7 billion in 2022. Alnylam Pharmaceuticals, Inc. (US).

article thumbnail

Bacteria Tag Team Tumors with T Cells

Medgadget

Creating such bacterial/T cell tag teams could expand the variety of cancers that can be treated using T cell therapy and also enhance the tumor cell killing effects of T cells. CAR T cells are white blood cells that have been primed to attack cancer cells. .”